![]() ![]() article Measuring Health Outcomes: The Outcome Hierarchy, New England Journal of Medicine, December 2010. ![]() Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. Its time for a fundamentally new strategy. Available at (accessed 17 April 2016).ĭrazen JM, Curfman GD. N Engl J Med 1993 329: 570–571.īritish Parachute Association Injury/Fatality Rates, 2007. Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. Financial conflicts of interest in biomedical research. Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Promotional tone in reviews of menopausal hormone therapy after the women's health initiative: an analysis of published articles. ![]() 5 Other journals, such as the Journal of the American Medical Association ( JAMA) and Annals of Internal Medicine maintain a disclosure policy for relevant conflicts of interest for editorial writers.įugh-Berman A, McDonald CP, Bell AM, Bethards EC, Scialli AR. Our goal is to build a community that takes a sophisticated approach to evaluating evidence and assessing its impact on. With a current journal impact factor of 176.079 (2021 Journal Citation Reports®, Source Clarivate, 2022), NEJM is a top-ranking medical journal in the general medicine category.It is also ranked as a top essential journal by physicians in 11 specialties (2019 Essential Journal Study, The Matalia Group). 2 This policy was re-affirmed in 1993 by editors Jerome Kassirer and Marcia Angell, 3 but in 2002, citing difficulty in recruiting authors, Jeffrey Drazen and Gregory Curfman relaxed this requirement, and instituted the current policy where editorialists ‘not have any significant financial interest in any biomedical company relevant to the topics and products discussed in the article 4’, where significant became defined as $10 000 or less in financial conflicts. In 1990 under editor and chief Arnold Relman, the New England Journal of Medicine ( NEJM) introduced a policy of recusal for editorialists with financial ties to drugs or devices discussed in the editorial. 1 How financial conflicts among editorialists should be managed-whether disclosure or recusal is necessary-has been a longstanding debate in medicine. Psoriasis is a common chronic, inflammatory skin disease that affects approximately 6 million people in the United States, crossing the boundaries of sex, age, and race. Prior studies have shown that financial relationships between editorialists and the biopharmaceutical industry are associated with increased likelihood of favorable descriptions of evidence, even when that evidence is unfavorable. Original Article from The New England Journal of Medicine 20-Year Risks of Breast-Cancer. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |